Crossmark

Comparison of ciprofloxacin and aminoglycoside susceptibility testing for ceftriaxone non-susceptible Enterobacterales by disk diffusion and VITEK 2 vs. broth microdilution using updated Clinical and Laboratory Standards Institute breakpoints

Crossref DOI link: https://doi.org/10.1186/s12866-025-03923-7

Published Online: 2025-03-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sohani, Zahra N.

Lieu, Anthony

Semret, Makeda

Cheng, Matthew P.

Simic, Nancy

Bamba, Reggie

Patel, Mina

Lawandi, Alexander

Lee, Todd C.
License Information

Text and Data Mining valid from 2025-03-31

Version of Record valid from 2025-03-31
More Information

Article History

Received: 4 July 2024

Accepted: 21 March 2025

First Online: 31 March 2025

Declarations

:

: This research study was conducted retrospectively from laboratory specimens obtained for quality control purposes, consent from individual human participants was waived from ethical approval by the MUHC Institutional Review Board in accordance with Article 5.5 of the Tri-Council Policy Statement (TCPS-2).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below